EFFERALGAN 250 mg, dispersible tablet 12 tablets
Brand page: Doliprane, Dafalgan, Efferalgan (paracetamol) — all forms and strengths in France
Active ingredients: Paracetamol
Commercialized according to BDPM
Dispersible tablet12 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EFFERALGAN 250 mg, comprimé dispersible
- Pharmaceutical form
- comprimé dispersible
- Route of administration
- orale
- Presentation description
- 12 plaquette(s) polyamide PVC-Aluminium aluminium polytéréphtalate (PET) de 1 comprimé(s)
- Marketing authorisation holder
- ETHYPHARM
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Jan 2021
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66826710CIP73463657CIP133400934636578Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PARACÉTAMOLcomprimé | 250 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.